it was demonstrated clinically and instrumentally ( ecg , rhythmography , bicycle ergometry with standard exercise , cardiac rhythm monitoring and computer analysis , polycardiography , tetrapolar chest rheography ) that ethmozine 's antiarrhythmic effect was marked ( a more than 75 % post-treatment decline in the frequency of extrasystoles at rest and during exercise , provided that paired polytopic extrasystoles and paroxysms of tachycardia are suppressed completely ) in 52.1 % of sves patients and 60 % of ves patients .
C0340464
extrasystoles
C0033036
sves